Kulatthadi Kwatha In The Management Of Tamak Swasa(Bronchial Asthma)

A Clinical Evaluation Of‘Kulatthadi Kwatha’In The Management Of Tamaka Swasa(Bronchial Asthma) - NILL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057474

Enrollment

Registered

2023-09-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Chronicity- below 10 years. 2 Patient willing to sign the consent form. 3 The patients between the age group of 10 to 70 years of either sex presenting with clinical features of Tamaka Swasa (Bronchial asthma or allergic bronchial asthma) like, breathlessness, wheeze, paroxysm of attack, cough etc. irrespective of Sex & Religion. 4 Patients having FEV1 >60% of predicted value.

Exclusion criteria

Exclusion criteria: 1 Age below 10 and above 70 years. 2 Patients having asthma due to secondary causes such as drug induced like aspirin. 3 Pregnant women and lactating mothers. 4 Patients having concomitant systemic illness like uncontrolled hypertension, poorly controlled diabetes mellitos, renal failure, malignancy, acute or chronic liver disease.

Design outcomes

Primary

Measure	Time frame
To Assessment Of Subjective And Objective Parameter Before And After Treatment.Timepoint: 45 DAYS	—

Secondary

Measure	Time frame
To observe any side effects if occur during clinical trial. Timepoint: 45 DAYS	—

Countries

India

Contacts

Public ContactDr Brahmanand Sharma

Post Graduate Institute Of Ayurved Jodhpur Rajasthan

bkmudgal9@gmail.com9460318138

Outcome results